Development of a novel centrosome-related risk signature to predict prognosis and treatment response in lung adenocarcinoma
Our work develops a novel centrosome-related prognostic signature that accurately predicts OS in LUAD and can assist in clinical diagnosis and treatment.
Authors
- Chaoqun Lian (ORCID: https://orcid.org/0000-0003-4914-020X)
- Jiaojiao Fei
- Chao Zuo (ORCID: https://orcid.org/0000-0002-1461-0032)
- Shengping Min
- Jing Zhang (ORCID: https://orcid.org/0000-0002-2488-5021)
- Luyao Wang (ORCID: https://orcid.org/0000-0003-1595-6593)
- Ziqiang Wang (ORCID: https://orcid.org/0000-0002-0410-2640)
- Xiaojing Wang (ORCID: https://orcid.org/0000-0001-6285-9193)
- Huili Chen
- Yiluo Xie
Institutions
- Bengbu Medical College (CN)
- Guilin Medical University (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1007/s12672-024-01615-8
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National Natural Science Foundation of China